University of Miami Miller School-led technology paves way for islet regeneration in human pancreas – Newswise
stemadminStem Cell MedicineNo comments

Newswise Scientists focused on finding better treatments or cures for types 1 or 2 diabetes are painfully aware of current limitations, including having to use animal tissue in studies that often dont translate to human trials. New research published June 29 in Nature Communications could help researchers overcome some of the biggest challenges of taking diabetes research from the lab to human trials and the clinic. By using a technology first developed at the University of Miami Miller School of Medicine along with a Miller School patented approach to enhance the oxygenation of cultured tissues, researchers will likely be able to conduct real-time regeneration and development studies in the human pancreas

Read more
Study reveals key role of a protein in regulating scar tissue growth after heart attacks – News-Medical.net
stemadminStem Cell MedicineNo comments

Reviewed by Emily Henderson, B.Sc.Jul 6 2020 New UCLA research conducted in mice could explain why some people suffer more extensive scarring than others after a heart attack. The study, published in the journal Cell, reveals that a protein known as type 5 collagen plays a critical role in regulating the size of scar tissue in the heart.

Read more
The first cell therapy for COVID-19 reduces mortality in critically ill patients – Explica
stemadminStem Cell MedicineNo comments

Pioneering research by Spanish researchers has proven to be efficient for the clinical improvement of critical cases of COVID-19. The work, the largest so far, has been published in the journal The Lancet EClinicalMedicine, after demonstrating that an advanced treatment based on cell therapy, tested in 13 patients intubated in mechanical ventilation, reduces the mortality of critically ill coronavirus patients from 85% to 15%, that is, 70%. This is the first results of the BALMYS-19 project, co-led by a professor at the Miguel Hernndez University (UMH) in Elche and researcher at the Alicante Institute of Health Research (ISABIAL) Bernat Soriatogether with the teacher Damin Garca-Olmo from the Jimnez Daz Foundation (Autonomous University of Madrid).

Read more
Oncologie Expands and Strengthens Management Team with Key Appointments and Promotions – BioSpace
stemadminStem Cell MedicineNo comments

WALTHAM, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- Oncologie, Inc., a precision medicine company using an innovative RNA-based biomarker platform to develop novel, targeted oncology therapies, today announced an expansion of its management team with the appointments of Matthew Osborne as Chief Financial Officer, Hagop Youssoufian, M.D., as Interim Chief Medical Officer, Bill McDonald, Ph.D., as Vice President of Chemistry, Manufacturing and Controls (CMC), as well as the promotion of Kerry Culm-Merdek, Ph.D., to Vice President of Clinical Development. We are pleased to expand Oncologies management team with the additions of Matt, Hagop and Bill, and the promotion of Kerry, and look forward to their contributions, said Laura Benjamin, Ph.D., Founder and CEO of Oncologie. Their collective experience and leadership will be critical as we further develop and deploy our RNA-based biomarker platform to advance the state of the art of precision medicine to identify the right patients for our clinical stage programs, Navicixizumab and Bavituximab.

Read more
Joint Study by Sunway University and Harvard Medical School Shows Gene Therapy Can Advance Cancer Treatment – QS WOW News
stemadminStem Cell MedicineNo comments

Sunway Universitys Professor Jeff Tan Kuan Onn of the Department of Biological Sciences and Professor Poh Chit Laa from the Centre for Virus and Vaccine Research, along with their research collaborators from Harvard Medical Schools Center for Stem Cell Therapeutics and Imaging (USA) as well as University of Tennessee Health Science Centre (USA) have completed a study that has demonstrated the efficacy of molecular gene therapy as a new strategy for cancer treatment. The research could potentially contribute to shorter treatment time for cancers, reduce treatment costs and minimize the adverse effects of current chemo-drugs in cancer patients such as susceptibilities toward microbial infections, hair loss, and other side effects of chemo-drugs that drastically affect the quality of life of cancer patients undergoing therapy. Principal Investigator Professor Jeff Tan explained, Currently, chemo-drugs are relatively ineffective against cancer cells that have developed drug-resistance resulting in the need for high doses of chemo-drugs or a combination of chemo-drugs to be administered to patients with cancer cells

Read more
Stem Cell Therapy Market Segmentation Detailed Study with Forecast to 2025 – Owned
stemadminStem Cell MedicineNo comments

Global Stem Cell Therapy Market: Overview Also called regenerative medicine, stem cell therapy encourages the reparative response of damaged, diseased, or dysfunctional tissue via the use of stem cells and their derivatives. Replacing the practice of organ transplantations, stem cell therapies have eliminated the dependence on availability of donors. Bone marrow transplant is perhaps the most commonly employed stem cell therapy.

Read more
The Pershing Square Foundation Awards $3 Million to Innovative SARS-CoV-2 Research Projects – Business Wire
stemadminStem Cell MedicineNo comments

NEW YORK--(BUSINESS WIRE)--The Pershing Square Foundation (the Foundation) today announced that it has awarded $3 million to nineteen recipients at ten academic research institutions conducting research related to the SARS-CoV-2 virus. As scientists across various disciplines around the world have risen to the challenge of combatting SARS-CoV-2, the Foundation worked with its network of talented cancer research scientists and physician-scientists involved in the Pershing Square Sohn Cancer Research Alliance (PSSCRA) to create a funding opportunity for SARS-CoV-2 research. The Foundations PSSCRA initiative annually awards a cancer research prize that provides funding and emboldens early-career investigators to pursue research projects at a stage when traditional funding is lacking

Read more

Theme: Illdy.